Quantitative Structure-Activity Relationship Studies of 4-Imidazolyl- 1,4-dihydropyridines as Calcium Channel Blockers

Objective(s): The structure- activity relationship of a series of 36 molecules, showing L-type calcium channel blocking was studied using a QSAR (quantitative structure–activity relationship) method. Materials and Methods: Structures were optimized by the semi-empirical AM1 quantum-chemical method which was also used to find structure-calcium channel blocking activity trends. Several types of descriptors, including electrotopological, structural and thermodynamics were used to derive a quantitative relationship between L-type calcium channel blocking activity and structural properties. The developed QSAR model contributed to a mechanistic understanding of the investigated biological effects. Results: Multiple linear regressions (MLR) was employed to model the relationships between molecular descriptors and biological activities of molecules using stepwise method and genetic algorithm as variable selection tools. The accuracy of the proposed MLR model was illustrated using cross-validation, and Y-randomisation -as the evaluation techniques. Conclusion: The predictive ability of the model was found to be satisfactory and could be used for designing a similar group of 1,4- dihydropyridines , based on a pyridine structure core which can block calcium channels.

[1]  M. Ganjali,et al.  Investigation of different linear and nonlinear chemometric methods for modeling of retention index of essential oil components: concerns to support vector machine. , 2009, Journal of hazardous materials.

[2]  A. Shafiee,et al.  Syntheses and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent. , 1998, Pharmaceutica acta Helvetiae.

[3]  Bjørn K. Alsberg,et al.  A new 3D molecular structure representation using quantum topology with application to structure–property relationships , 2000 .

[4]  M. Ganjali,et al.  Exploring QSARs for Antiviral Activity of 4‐Alkylamino‐6‐(2‐hydroxyethyl)‐2‐methylthiopyrimidines by Support Vector Machine , 2008, Chemical biology & drug design.

[5]  A M Triggle,et al.  1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach. , 1988, Journal of medicinal chemistry.

[6]  J. Hunger,et al.  Optimization and analysis of force field parameters by combination of genetic algorithms and neural networks , 1999, J. Comput. Chem..

[7]  Chris L. Waller,et al.  Development and Validation of a Novel Variable Selection Technique with Application to Multidimensional Quantitative Structure—Activity Relationship Studies. , 1999 .

[8]  T. Takenaka,et al.  Synthesis of new water-soluble dihydropyridine vasodilators. , 1979, Chemical & pharmaceutical bulletin.

[9]  Johann Gasteiger,et al.  Prediction of 1H NMR chemical shifts using neural networks. , 2002, Analytical chemistry.

[10]  C. Triggle,et al.  Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates. , 1986, Journal of medicinal chemistry.

[11]  Bahram Hemmateenejad,et al.  Multiple Linear Regression and Principal Component Analysis‐Based Prediction of the Anti‐Tuberculosis Activity of Some 2‐aryl‐1,3,4‐Thiadiazole Derivatives , 2006 .

[12]  Y. Mori,et al.  Structural determinants of ion selectivity in brain calcium channel , 1993, FEBS letters.

[13]  T. Godfraind.  Calcium Channel Blockers , 2004, Milestones in Drug Therapy.

[14]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[15]  W. Matowe,et al.  Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates. , 1998, Journal of medicinal chemistry.

[16]  C. Hansch,et al.  Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. , 2001, Chemical reviews.

[17]  Chris L. Waller,et al.  Development and Validation of a Novel Variable Selection Technique with Application to Multidimensional Quantitative Structure-Activity Relationship Studies , 1999, J. Chem. Inf. Comput. Sci..

[18]  M. Ganjali,et al.  Development and Validation of a Rapid Chemometrics-Assisted Spectrophotometry and Liquid Chromatography Methods for the Simultaneous Determination of the Phenylalanine, Tryptophan and Tyrosine in the Pharmaceutical Products , 2008 .

[19]  U Depczynski,et al.  Genetic algorithms applied to the selection of factors in principal component regression , 2000 .

[20]  F. Hadizadeh,et al.  Synthesis and calcium channel antagonist activity of 4-[(halobenzyl )imidazolyl] dihidropyridines , 2009 .

[21]  S. Howlett,et al.  Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers. , 1995, Journal of medicinal chemistry.

[22]  P. Khadikar,et al.  QSAR prediction of toxicity of nitrobenzenes. , 2001, Bioorganic & medicinal chemistry.

[23]  M. Ganjali,et al.  QSAR Study of 2‐(1‐Propylpiperidin‐4‐yl)‐1H‐Benzimidazole‐4‐Carboxamide as PARP Inhibitors for Treatment of Cancer , 2008, Chemical biology & drug design.

[24]  B. Hemmateenejad,et al.  Conformational analysis of some new derivatives of 4-nitroimidazolyl-1,4-dihydropyridine-based calcium channel blockers , 2005 .

[25]  Eslam Pourbasheer,et al.  Development of a New Combined Chemometrics Method, Applied in the Simultaneous Voltammetric Determination of Cinnamic Acid and 3, 4-Dihydroxy Benzoic Acid , 2009 .

[26]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[27]  Lori L. Isom,et al.  Auxiliary subunits of voltage-gated ion channels , 1994, Neuron.

[28]  R. Leardi,et al.  Genetic algorithms applied to feature selection in PLS regression: how and when to use them , 1998 .

[29]  Eslam Pourbasheer,et al.  Support Vector Machine‐Based Quantitative Structure–Activity Relationship Study of Cholesteryl Ester Transfer Protein Inhibitors , 2009, Chemical biology & drug design.

[30]  Hugh M. Cartwright,et al.  Applications of artificial intelligence in chemistry , 1993 .

[31]  A. Fleckenstein.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.

[32]  W. Catterall,et al.  Receptor sites for Ca2+ channel antagonists. , 1992, Trends in pharmacological sciences.

[33]  M. Ganjali,et al.  QSPR Study of the Distribution Coefficient Property for Hydantoin and 5‐Arylidene Derivatives. A Genetic Algorithm Application for the Variable Selection in the MLR and PLS Methods , 2008 .